Exogenous vimentin overexpression in butyrate‐sensitive CRC cells such as HCT‐116 is expected to promote a more EMT‐like phenotype and allow for increased resistance to the effects of butyrate and HDACis. Here, VIM is linked to colorectal carcinoma.